The role of mutation testing in patients with chronic myeloid leukemia in chronic phase after imatinib failure and their outcomes after treatment modification: Single-institutional experience over 13 years-Reference-Cited by-同舟云学术

The role of mutation testing in patients with chronic myeloid leukemia in chronic phase after imatinib failure and their outcomes after treatment modification: Single-institutional experience over 13 years

Published:2017 Issue:3 Volume:38 Page:328
ISSN:0971-5851
Container-title:Indian Journal of Medical and Paediatric Oncology
language:en
Short-container-title:Indian J Med Paediatr Oncol

Author:

Kumar KarnamAshok,Chaitanya PuligundlaKrishna,Stalin Bala,Sadashivudu Gundeti,Srinivas MaddaliLakshmi

Publisher

Georg Thieme Verlag KG

Subject

Oncology,Pediatrics, Perinatology and Child Health

Reference31 articles.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Secondary Mutations of Type II Kinase Inhibitors;Journal of Medicinal Chemistry;2024-06-05

2. A Retrospective Analysis of BCR-ABL-1 Kinase Domain Mutations in Frontline TKI Resistant Chronic Myeloid Leukemia Patients: A Single Centre Experience;Indian Journal of Hematology and Blood Transfusion;2024-04-23

3. BCR-ABL kinase domain mutations in CML patients, experience from a tertiary care center in North India;Leukemia Research Reports;2024

4. Identification by molecular dynamic simulation and in vitro validation of SISB-A1, N-[1-(4-bromophenyl)-3-methyl-1H-pyrazol-5-yl]-2-[(2-oxo-4-phenyl-2H-chromen-7-yl) oxy], as an inhibitor of the AblT315I mutant kinase to combat imatinib resistance in chronic myeloid leukemia;Medical Oncology;2023-10-03

5. A Retrospective Analysis of BCR-ABL1 Kinase Domain Mutations in the Frontline Drug Intolerant or Resistant Chronic Myeloid Leukemia Patients: An Indian Experience from a High-End Referral Laboratory;South Asian Journal of Cancer;2022-12-31